Acrotech Biopharma Inc drugs
3 results
Beleodaq (belinostat)
(Belinostat)Acrotech Biopharma Inc
Usage: Beleodaq is indicated for adults with relapsed or refractory peripheral T-cell lymphoma (PTCL). Its approval is under accelerated conditions based on tumor response and duration, without established improvements in survival or symptoms. Continued approval may depend on further verification of clinical benefits.
Folotyn (pralatrexate)
(pralatrexate)Acrotech Biopharma Inc
Usage: FOLOTYN is indicated for treating patients with relapsed or refractory peripheral T-cell lymphoma (PTCL). This use is under accelerated approval based on overall response rate, with continued approval dependent on confirming clinical benefits in further trials.
Zevalin (ibritumomab tiuxetan)
(ibritumomab tiuxetan)Acrotech Biopharma Inc
Usage: Zevalin is indicated for adult patients with relapsed or refractory low-grade or follicular B-cell non-Hodgkin's lymphoma (NHL) and for those with previously untreated follicular NHL who respond to first-line chemotherapy.